Spotlight -

Long-Acting Injectable Therapy in the Management of Adult Patients with Schizophrenia|

Major Depressive Disorder

Paras Gupta, MBE

Articles by Paras Gupta, MBE

Ktsdesign/AdobeStock

The Impact of Selective Serotonin Reuptake Inhibitors on Bleeding Risk: A Comprehensive Review

ByParas Gupta, MBE,Sarah Hakam, BS,Arsalan Nisar, MS,Inna D'Empaire, MD,Gina Jamal, MD,Reza Safavi, MD

February 3rd 2025

What patients are at risk when taking SSRIs?

Latest Updated Articles

The Impact of Selective Serotonin Reuptake Inhibitors on Bleeding Risk: A Comprehensive Review
February 3rd 2025

Trending on Psychiatric Times

The Psychiatric Pipeline in Review: Quarter 3, 2026

Psychedelics as a Catalyst for Change: The Evolving Competitive Landscape in Depression

September 2026 in Review: Updates on the Psychiatric Treatment Pipeline, FDA News

VA Expands Informed Consent Requirements for Psychotropic Medications Starting in 2027

Nature vs Nurture: The Interplay Between Genetics and Environmental Influences